{
    "title": "GSK escapes Advair hit for now as second generic bid fails",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-4494832/GSK-dodges-bullet-second-generic-Advair-bid-fails.html",
    "date": "2017-05-11",
    "keywords": [
        "advair",
        "hikma",
        "gsk",
        "year",
        "application",
        "drug",
        "fda",
        "mylan",
        "response",
        "percent",
        "guidance",
        "competition",
        "lung",
        "cutprice",
        "threat",
        "thursday",
        "version",
        "firm",
        "approval",
        "vectura",
        "copy",
        "product",
        "amendment",
        "agency",
        "substitute",
        "hirschler",
        "london",
        "glaxosmithkline",
        "blockbuster",
        "form",
        "medicine",
        "industry",
        "mid2018",
        "drugmaker",
        "profit",
        "boost",
        "food",
        "administration",
        "treatment",
        "asthma",
        "disease",
        "time",
        "partner",
        "race",
        "delay",
        "trading",
        "process",
        "material",
        "inhaler",
        "device",
        "generic",
        "march",
        "wednesday",
        "decision",
        "analyst",
        "michael",
        "europe",
        "nonetheless",
        "discount",
        "anticipation",
        "arrival",
        "launch",
        "market",
        "share",
        "midyear",
        "spokesman",
        "company",
        "pence",
        "dividend",
        "morning",
        "trade",
        "challenge",
        "executive",
        "emma",
        "walmsley",
        "month",
        "number",
        "respiratory",
        "loss",
        "competitor",
        "fluticasone",
        "propionate",
        "salmeterol",
        "group",
        "turnover",
        "weir",
        "edmund",
        "blair"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}